Suven Life Sciences (NSE:SUVEN) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUVEN Suven Life Sciences Ltd NSE:SUVEN
47 GF Score
Price ₹307.10
GF Value ₹96.25
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Suven Life Sciences Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:SUVEN vs ZTS: Short Percentage of Float Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Suven Life Sciences's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suven Life Sciences Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Suven Life Sciences's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Suven Life Sciences's Short Percentage of Float falls into.


NSE:SUVEN
47GF Score
Suven Life Sciences Ltd NSE:SUVEN
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Suven Life Sciences (NSE:SUVEN) Overvalued in 2026?

Based on GuruFocus' analysis, Suven Life Sciences stock appears to be overvalued. The current stock price of ₹307.10 is trading 219.1% above its estimated GF Value™ of ₹96.25. GuruFocus considers Suven Life Sciences to be Significantly Overvalued.

Key valuation signals for NSE:SUVEN:

  • Short Percentage of Float:
  • GF Value™: ₹96.25 vs. price of ₹307.10 (219.1% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the NSE:SUVEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Suven Life Sciences Business Description

Other Exchanges 530239:India
Address Avenue 7, Road No. 5, Banjara Hills, Number 8-2-334, 6th Floor, SDE Serene Chambers, Hyderabad, TG, IND, 500 034
Suven Life Sciences Ltd is an India-based biopharmaceutical company. The company is focused on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. The company's only segment is providing Research and Development services. The company's geographical segment includes India; the USA; Europe and Others. The company generates maximum revenue from the USA. The company earns revenue from the sale of New Chemical Entity (NCE) based Intermediates for CNS disorders.
47GF Score

Get the complete analysis for NSE:SUVEN

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹307.10
Price
₹96.25
GF Value